A

Aurinia (AUPH)

$000.00 0.00% ($0.00)

  • Today
  • Week
  • Month
  • Year
  • 5 Year
  • YTD

About Aurinia (AUPH)

Aurinia Pharmaceuticals Inc. is a Canada-based clinical-stage biopharmaceutical company operating in the field of nephrology and autoimmunity. The Company's primary business is the development of a therapeutic drug to treat autoimmune diseases, in pa... Read more

  • 4.76
  • 4.88
  • 4.64
  • 24.45
  • -7.2%
  • 166M
  • 0.00
  • 2.38M
  • 725M
  • 4.49
  • -75%
  • %

More Stock Analysis & Reports

Access to easy in-depth stock analysis and reports from Refinitiv with analyst estimates on share price movements.